MD Anderson and Sibylla Biotech Announce Strategic Collaboration to Discover and Develop Small-Molecule Protein Degraders
June 13, 2024
June 13, 2024
HOUSTON, Texas, June 13 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Sibylla's PPI-FIT technology joins with MD Anderson's drug development resources and expertise to create protein folding interfering degraders as cancer therapies
* * *
The University of Texas MD Anderson Cancer Center and Sibylla Biotech today announced a strategic collaboration agreement to discover a . . .
* * *
Sibylla's PPI-FIT technology joins with MD Anderson's drug development resources and expertise to create protein folding interfering degraders as cancer therapies
* * *
The University of Texas MD Anderson Cancer Center and Sibylla Biotech today announced a strategic collaboration agreement to discover a . . .